EXHIBIT 16.1
Published on March 2, 2009
Exhibit
16.1
February
27, 2009
Securities
and Exchange Commission
100 F
Street, NE
Washington,
DC 20549
Dear
Ladies and Gentlemen:
We are
the former independent registered public accounting firm for Rexahn
Pharmaceuticals, (the "Company"). We have read the Company's disclosure set
forth in Item 4.01 "Changes in Registrant's Certifying Accountant" of the
Company's Current Report on Form 8-K/A dated March 2, 2009 (the "Current
Report") and are in agreement with the disclosure in the Current Report, insofar
as it pertains to our firm.
Sincerely,
/s/ Lazar
Levine & Felix LLP